194 results on '"Lewis, Hal"'
Search Results
2. The Jewish Studies Professor as Communal Leader
3. Pemphigus foliaceus in a patient with gastrointestinal stromal tumor treated with adjuvant imatinib mesylate
4. Dermatology ECHO - an innovative solution to address limited access to dermatology expertise
5. One day diving on the Queensland Coast
6. Scaffold modifications to the 4-(4,4-dimethylpiperidinyl) 2,6-dimethylpyridinyl class of HIV-1 allosteric integrase inhibitors
7. Classification for Big Dataset of Bioacoustic Signals Based on Human Scoring System and Artificial Neural Network
8. Immune-modulating enzyme indoleamine 2,3-dioxygenase is effectively inhibited by targeting its apo-form
9. Western Region Faculty Institute for Training. Early Education Program for Children with Disabilities. Final Report.
10. Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors
11. Synthesis and biological evaluation of biaryl alkyl ethers as inhibitors of IDO1
12. The Tetranucleotide UCAY Directs the Specific Recognition of RNA by the Nova K-Homology 3 Domain
13. Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-b]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors
14. Structure–activity relationship (SAR) studies on substituted N-(pyridin-3-yl)-2-amino-isonicotinamides as highly potent and selective glycogen synthase kinase-3 (GSK-3) inhibitors
15. Structure-Activity Relationship (SAR) Studies on Substituted 2-(Pyridin-2-ylamino)-N-(pyridin-3-yl)isonicotinamide as Highly Potent, Selective and Brain Penetrant Glycogen Synthase Kinase-3 (GSK-3) Inhibitors
16. Discovery and Preclinical Profiling of GSK3839919, a Potent HIV-1 Allosteric Integrase Inhibitor
17. Design, Synthesis, and Preclinical Profiling of GSK3739936 (BMS-986180), an Allosteric Inhibitor of HIV-1 Integrase with Broad-Spectrum Activity toward 124/125 Polymorphs
18. Core Modifications to the 4-(4,4-Dimethylpiperidinyl) 2,6-Dimethylpyridinyl Class of Hiv-1 Allosteric Integrase Inhibitors
19. Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers
20. SGX393 Inhibits the CML Mutant ${\rm Bcr}\text{-}{\rm Abl}^{{\rm T}315{\rm I}}$ and Preempts in vitro Resistance When Combined with Nilotinib or Dasatinib
21. 70 Jewish leaders, thinkers, and clergy respond to the question: what will be the condition of the Jewish community 50 years from now?
22. RAILROADS AND SLAVERY: Readers Respond
23. Moses and the Journey to Leadership: Timeless Lessons of Effective Management from the Bible and Today's Leaders
24. SGX393 inhibits the CML mutant [Bcr-Abl.sup.T3151] and preempts in vitro resistance when combined with nilotinib or dasatinib
25. Human Apolipoprotein E4 Worsens Acute Axonal Pathology but Not Amyloid-β Immunoreactivity After Traumatic Brain Injury in 3xTG-AD Mice
26. An Unnamed Species of Ranularia (Gastropoda Cymatiidae) from Australia
27. Neutrophil‐predominant bullous pemphigoid induced by checkpoint inhibitors: A case series
28. Discovery and Optimization of Novel Pyrazolopyrimidines as Potent and Orally Bioavailable Allosteric HIV-1 Integrase Inhibitors
29. Sequence-specific RNA binding by a Nova KH domain: implications for paraneoplastic disease and the fragile X syndrome
30. Structures of a minimal human CFTR first nucleotide-binding domain as a monomer, head-to-tail homodimer, and pathogenic mutant
31. Petitioning for a revised statement on climate change
32. BrainSTARS: pilot data on a team-based intervention program for students who have acquired brain injury
33. STRUCTURE OF THE HUMAN CFTR NBD1 DOMAIN AS A HOMODIMER: INSIGHTS AND APPLICATIONS: S1.2
34. 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors
35. Discovery of new acylaminopyridines as GSK-3 inhibitors by a structure guided in-depth exploration of chemical space around a pyrrolopyridinone core
36. Methotrexate-induced cutaneous ulceration in 3 nonpsoriatic patients: Report of a rare side effect
37. Initial Clinical Guidelines for Co-Occurring Autism Spectrum Disorder and Gender Dysphoria or Incongruence in Adolescents
38. For 3751, it's sweet to be back: California's only operating 4-8-4 strides triumphantly into San Diego for the first time since 1953
39. Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors
40. Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors
41. Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents
42. Channel Gating Regulation by the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) First Cytosolic Loop
43. OVERUSE OF MAGNETIC RESONANCE IMAGING IN THE DIAGNOSIS AND TREATMENT OF MODERATE TO SEVERE OSTEOARTHRITIS.
44. With new technology, nonprofits can achieve longtime missions
45. Evidence-Based Approach of Treatment Options for Postoperative Knee Pain
46. An effective day treatment model for young children with pervasive developmental disorders
47. Discovery of S3-Truncated, C-6 Heteroaryl Substituted Aminothiazine β-Site APP Cleaving Enzyme-1 (BACE1) Inhibitors.
48. Discovery of Isonicotinamides as Highly Selective, Brain Penetrable, and Orally Active Glycogen Synthase Kinase-3 Inhibitors.
49. BrainSTARS
50. SGX393 inhibits the CML mutant Bcr-Abl T315I and preempts in vitro resistance when combined with nilotinib or dasatinib
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.